The enduring importance of animal models in understanding periodontal disease

Virulence

Volumn 6, Issue 3, 2015, Pages 229-235

  Hajishengallis, George ^a   Lamont, Richard J ^b   Graves, Dana T ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Dysbiosis; Immune subversion; Inflammation; Periodontitis; Systemic disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 2; COMPLEMENT; COMPLEMENT COMPONENT C5A RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 8; OSTEOCLAST DIFFERENTIATION FACTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; AUTACOID;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE LOSS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; DYSBIOSIS; GENE EXPRESSION; HOST RESISTANCE; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; LEUKOCYTE ADHESION DEFICIENCY; METAGENOMICS; MICROBIAL COMMUNITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; REVIEW; STREPTOCOCCUS GORDONII; VIRUS GENE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PERIODONTITIS;

ANIMALIA; BACTERIA (MICROORGANISMS);

ALVEOLAR BONE LOSS; ANIMALS; DISEASE MODELS, ANIMAL; DYSBIOSIS; INFLAMMATION MEDIATORS; PERIODONTAL DISEASES; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

EID: 84924383379     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/21505594.2014.990806     Document Type: Review

References (102)

1. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008; 35:89-105; PMID:18199146; http://dx.doi.org/10.1111/j.1600- 051X.2007.01172.xp
2. Baker PJ, Dixon M, Roopenian DC. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun 2000; 68:5864-8; PMID:10992496
3. Abe T, Hajishengallis G. Optimization of the ligatureinduced periodontitis model in mice. J Immunol Meth 2013; 394:49-54; PMID:23672778; http://dx. doi.org/10.1016/j.jim.2013.05.002
4. Genco CA, Cutler CW, Kapczynski D, Maloney K, Arnold RR. A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun 1991; 59:1255-63; PMID:2004807
5. Burns E, Bachrach G, Shapira L, Nussbaum G. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 2006; 177:8296- 300; PMID:17142724
6. Singh A, Wyant T, Anaya-Bergman C, Aduse-Opoku J, Brunner J, Laine ML, Curtis MA, Lewis JP. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infect Immun 2011; 79:4533-42; PMID:21911459
7. Kastelein P, van Steenbergen TJ, Bras JM, de Graaff J. An experimentally induced phlegmonous abscess by a strain of Bacteroides gingivalis in guinea pigs and mice. Antonie Van Leeuwenhoek 1981; 47:1-9; PMID:7247390
8. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol 2011; 7:738-48; PMID:21709707; http://dx.doi.org/10.1038/nrendo. 2011.106
9. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010; 8:481- 90; PMID:20514045; http://dx.doi.org/; http://dx. doi.org/10.1038/nrmicro2337
10. Keyes PH, Jordan HV. Periodontal lesions in the syrian hamster. III. Findings related to an infectious and transmissible component. Arch Oral Biol 1964; 32:377-400; PMID:14179047; http://dx.doi.org/ 10.1016/0003-9969(64)90024-X
11. Rovin S, Costich ER, Gordon HA. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res 1966; 1:193-204; PMID:4225530; http://dx. doi.org/10.1111/j.1600-0765.1966.tb01860.x
12. Williams RC, Leone CW, Jeffcoat MK, Nitzan D, Goldhaber P. Tetracycline treatment of periodontal disease in the beagle dog. II. The cultivable periodontal pocket flora. J Periodontal Res 1981; 16:666-74; PMID:6460865; http://dx.doi.org/10.1111/j.1600- 0765.1981.tb01005.x
13. Kenworthy R, Baverel M. Studies of a periodontal tissue lesion in the rat, untreated or treated with chlorhexidine digluconate. J Clin Periodontol 1981; 8:349-58; PMID:6947996; http://dx.doi.org/ 10.1111/j.1600-051X.1981.tb02044.x
14. Luan Q, Desta T, Chehab L, Sanders VJ, Plattner J, Graves DT. Inhibition of experimental periodontitis by a topical boron-based antimicrobial. J Dent Res 2008; 87:148-52; PMID:18218841; http://dx.doi. org/10.1177/154405910808700208
15. Weiner GS, DeMarco TJ, Bissada NF. Long term effect of systemic tetracycline administration on the severity of induced periodontitis in the rat. J Periodontol 1979; 50:619-23; PMID:294476; http://dx. doi.org/10.1902/jop.1979.50.12.619
16. Samejima Y, Ebisu S, Okada H. Effect of infection with Eikenella corrodens on the progression of ligature- induced periodontitis in rats. J Periodontal Res 1990; 25:308-15; PMID:2145416
17. Holt S, Ebersole J, Felton J, Brunsvold M, Kornman K. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988; 239:55-7; PMID:3336774; http://dx. doi.org/10.1126/science.3336774
18. Kuboniwa M, Tribble GD, James CE, Kilic AO, Tao L, Herzberg MC, Shizukuishi S, Lamont RJ. Streptococcus gordonii utilizes several distinct gene functions to recruit Porphyromonas gingivalis into a mixed community. Mol Microbiol 2006; 60:121-39; PMID:16556225; http://dx.doi.org/10.1111/j.1365- 2958.2006.05099.x
19. Daep CA, Novak EA, Lamont RJ, Demuth DR. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect Immun 2011; 79:67-74; PMID:21041492; http://dx.doi.org/ 10.1128/IAI.00361-10
20. Wright CJ, Wu H, Melander RJ, Melander C, Lamont RJ. Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors. Mol Oral Microbiol 2014; PMID:24899524
21. Ramsey MM, Rumbaugh KP, Whiteley M. Metabolite cross-feeding enhances virulence in a model polymicrobial infection. PLOS Pathog 2011; 7:e1002012; PMID:21483753
22. Stacy A, Everett J, Jorth P, Trivedi U, Rumbaugh KP, Whiteley M. Bacterial fight-and-flight responses enhance virulence in a polymicrobial infection. Proc Natl Acad Sci U S A 2014; 111:7819-24; PMID:24825893; http://dx.doi.org/10.1073/pnas.1400586111
23. Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 2014; 35:3-11; PMID:24269668; http://dx.doi.org/10.1016/j.it.2013.09.001
24. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: The Polymicrobial Synergy and Dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol 2012; 27:409- 19; PMID:23134607; http://dx.doi.org/10.1111/ j.2041-1014.2012.00663.x
25. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013; 62:1505-10; PMID:24037875; http://dx.doi.org/10.1136/gutjnl- 2012-303954
26. Jorth P, Turner KH, Gumus P, Nizam N, Buduneli N, Whiteley M. Metatranscriptomics of the human oral microbiome during health and disease. MBio 2014; 5:e01012-14; PMID:24692635; http://dx.doi. org/10.1128/mBio.01012-14
27. Page RC, Schroeder HE. Periodontitis in man and other animals-a comparative review. Basel, Switzerland: Karger; 1982.
28. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010; 8:564-77; PMID:20622892; http://dx.doi.org/ 10.1038/nrmicro2403
29. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 2011; 10:497-506; PMID:22036469; http:// dx.doi.org/10.1016/j.chom.2011.10.006
30. Hajishengallis G, Lamont RJ. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur J Immunol 2014; 44:328-38; PMID:24338806; http://dx.doi.org/10.1002/eji.201344202
31. Jiao Y, Darzi Y, Tawaratsumida K, Marchesan JT, Hasegawa M, Moon H, Chen GY, Nunez G, Giannobile WV, Raes J, et al. Induction of bone loss by pathobiontmediated nod1 signaling in the oral cavity. Cell Host Microbe 2013; 13:595-601; PMID:23684310; http:// dx.doi.org/10.1016/j.chom.2013.04.005
32. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, LakshmananA,WadeWG.Thehumanoralmicrobiome. J Bacteriol 2010; 192:5002-17;PMID:20656903; http://dx.doi.org/10.1128/JB.00542-10
33. Abusleme L, Dupuy AK, Dutzan N, Silva N, Burleson JA, Strausbaugh LD, Gamonal J, Diaz PI. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J 2013; 7:1016-25; PMID:23303375; http://dx.doi.org/10.1038/ismej.2012.174
34. Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK, Podar M, Leys EJ. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J 2012; 6:1176-85; PMID:22170420; http://dx.doi.org/ 10.1038/ismej.2011.191
35. Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 2006; 44:3665-73; PMID:17021095; http://dx.doi.org/10.1128/JCM.00317-06
36. Duran-Pinedo AE, Chen T, Teles R, Starr JR, Wang X, Krishnan K, Frias-Lopez J. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J 2014; 8:1659-72; PMID:24599074; http://dx.doi.org/10.1038/ismej. 2014.23
37. Klausen B, Evans RT, Ramamurthy NS, Golub LM, Sfintescu C, Lee JY, Bedi G, Zambon JJ, Genco RJ. Periodontal bone level and gingival proteinase activity in gnotobiotic rats immunized with Bacteroides gingivalis. Oral Microbiol Immunol 1991; 6:193-201; PMID:1687484; http://dx.doi.org/10.1111/j.1399- 302X.1991.tb00477.x
38. Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M, Page RC. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect Immun 1994; 62:1026-31; PMID:8112836
39. Gonzalez D, Tzianabos AO, Genco CA, Gibson FC, 3rd. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun 2003; 71:2283-7; PMID:12654858; http://dx.doi. org/10.1128/IAI.71.4.2283-2287.2003
40. O’Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J Immunol 2005; 175:3980-9; PMID:16148146; http://dx.doi.org/10.4049/ jimmunol.175.6.3980
41. Gibson FC, 3rd, Genco CA. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun 2001; 69:7959-63; PMID:11705986; http://dx.doi. org/10.1128/IAI.69.12.7959-7963.2001
42. Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect Immun 1991; 59:1529-34; PMID:1825991
43. Moutsopoulos NM, Konkel J, Sarmadi M, Eskan MA, Wild T, Dutzan N, Abusleme L, Zenobia C, Hosur KB, Abe T, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 2014; 6:229ra40; PMID:24670684; http://dx.doi.org/10.1126/scitranslmed.3007696
44. Williams R, Jeffcoat M, Kaplan M, Goldhaber P, Johnson H, Wechter W. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 1985; 227:640-2; PMID:3969553; http://dx.doi.org/ 10.1126/science.3969553
45. Li KL, Vogel R, Jeffcoat MK, Alfano MC, Smith MA, Collins JG, Offenbacher S. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. J Periodontal Res 1996; 31:525-32; PMID:8971650; http://dx.doi.org/10.1111/j.1600-0765.1996. tb00516.x
46. Assuma R, Oates T, Cochran D, Amar S, Graves D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immun 1998; 160:403-9; PMID:9551997
47. Delima A, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, Graves D. Soluble antagonists to interleukin- 1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001; 28:233-40; PMID:11284536; http://dx.doi.org/10.1034/j.1600- 051x.2001.028003233.x
48. Tomofuji T, Ekuni D, Irie K, Azuma T, Endo Y, Tamaki N, Sanbe T, Murakami J, Yamamoto T, Morita M. Preventive effects of a cocoa-enriched diet on gingival oxidative stress in experimental periodontitis. J Periodontol 2009; 80:1799-808; PMID:19905949; http:// dx.doi.org/10.1902/jop.2009.090270
49. Ekuni D, Tomofuji T, Irie K, Kasuyama K, Umakoshi M, Azuma T, Tamaki N, Sanbe T, Endo Y, Yamamoto T, et al. Effects of periodontitis on aortic insulin resistance in an obese rat model. Lab Invest 2010; 90:348-59; PMID:20065945; http://dx.doi. org/10.1038/labinvest.2009.141
50. Endo Y, Tomofuji T, Ekuni D, Irie K, Azuma T, Tamaki N, Yamamoto T, Morita M. Experimental periodontitis induces gene expression of proinflammatory cytokines in liver and white adipose tissues in obesity. J Periodontol 2010; 81:520-6; PMID:20367095; http:// dx.doi.org/10.1902/jop.2009.090574
51. Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B, Ellen R, Penninger J. Functional human Tcell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest, 2000; 106:R59-67; PMID:10995794; http:// dx.doi.org/10.1172/JCI10763
52. Han X, Kawai T, Eastcott JW, Taubman MA. Bacterialresponsive B lymphocytes induce periodontal bone resorption. J Immunol 2006; 176:625-31; PMID:16365458; http://dx.doi.org/10.4049/jimmunol.176.1.625
53. Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M, Jr., Kostenuik PJ, Giannobile WV. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007; 78:1300-8; PMID:17608585; http://dx.doi.org/10.1902/jop. 2007.070073
54. Eskan MA, Jotwani R, Abe T, Chmelar J, Lim JH, Liang S, Ciero PA, Krauss JL, Li F, Rauner M, et al. The leukocyte integrin antagonist Del-1 inhibits IL- 17-mediated inflammatory bone loss. Nat Immunol 2012; 13:465-73; PMID:22447028; http://dx.doi. org/10.1038/ni.2260
55. Maekawa T, Abe T, Hajishengallis E, Hosur KB, DeAngelis RA, Ricklin D, Lambris JD, Hajishengallis G. Genetic and intervention studies implicating complement C3 as amajor target for the treatment of periodontitis. J Immunol 2014; 192 6020-7; PMID:24808362; http://dx.doi.org/10.4049/jimmunol.1400569
56. Koide M, Suda S, Saitoh S, Ofuji Y, Suzuki T, Yoshie H, Takai M, Ono Y, Taniguchi Y, Hara K. In vivo administration of IL-1 beta accelerates silk ligatureinduced alveolar bone resorption in rats. J Oral Pathol Med 1995; 24:420-34; PMID:8537916; http://dx. doi.org/10.1111/j.1600-0714.1995.tb01212.x
57. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003; 38:198-203; PMID:12608915; http://dx.doi.org/10.1034/j.1600- 0765.2003.01395.x
58. Dayan S, Stashenko P, Niederman R, Kupper TS. Oral epithelial overexpression of IL-1alpha causes periodontal disease. J Dent Res 2004; 83:786-90; PMID:15381720; http://dx.doi.org/10.1177/ 154405910408301010
59. Baker P, Evans R, Roopenian D. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol 1994; 39:1035-40; PMID:7717884; http://dx.doi.org/ 10.1016/0003-9969(94)90055-8
60. Baker P, Dixon M, Evans R, Dufour L, Johnson E, Roopenian D. CD4(C) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999; 67:2804-9; PMID:10338484
61. Chiang C, Kyritsis G, Graves D, Amar S. Interleukin- 1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infection and Immunity 1999; 67:4231-6; PMID:10417196
62. Graves D, Oskoui M, Volejnikova S, Naguib G, Cai S, Desta T, Kakouras A, Jiang Y. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res 2001; 80:1875-9; PMID:11706944; http://dx.doi.org/10.1177/00220345010800100301
63. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 2007; 147:128-38; PMID:17177972
64. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013; 110:3507- 12; PMID:23401516; http://dx.doi.org/10.1073/ pnas.1222878110
65. Ebersole JL, Kirakodu S, Novak MJ, Stromberg AJ, Shen S, Orraca L, Gonzalez-Martinez J, Burgos A, Gonzalez OA. Cytokine Gene Expression Profiles during Initiation, Progression and Resolution of Periodontitis. J Clin Periodontol 2014; 41:853-61; PMID:24975876; http://dx.doi.org/10.1111/jcpe.12286
66. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008; 79:1585-91; PMID: 18673014
67. Glowacki AJ, Yoshizawa S, Jhunjhunwala S, Vieira AE, Garlet GP, Sfeir C, Little SR. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci U S A 2013; 110:18525-30; PMID:24167272; http://dx.doi.org/; http://dx.doi.org/10.1073/pnas.1302829110
68. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 2007; 43:85-101; PMID:17214837; http://dx.doi.org/10.1111/j.1600-0757.2006.00170.x
69. Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 1998; 66:1660-5; PMID:9529095
70. Takeuchi H, Hirano T, Whitmore SE, Morisaki I, Amano A, Lamont RJ. The serine phosphatase SerB of Porphyromonas gingivalis suppresses IL-8 production by dephosphorylation of NF-kB RelA/p65. PLOS Pathog 2013; 9:e1003326; PMID:23637609
71. Abe T, Hosur KB, Hajishengallis E, Reis ES, Ricklin D, Lambris JD, Hajishengallis G. Local complementtargeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist. J Immunol 2012; 189:5442-8; PMID:23089394; http://dx.doi.org/10.4049/jimmunol.1202339
72. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G. Microbial hijacking of complement- toll-like receptor crosstalk. Sci Signal 2010; 3: ra11; PMID:20159852
73. Maekawa T, Krauss JL, Abe T, Jotwani R, Triantafilou M, Triantafilou K, Hashim A, Hoch S, Curtis MA, Nussbaum G, et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 2014; 15:768- 78; PMID:24922578; http://dx.doi.org/10.1016/j. chom.2014.05.012
74. Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4’- phosphatase activities. Cell Microbiol 2009; 11:1587-99; PMID:19552698; http://dx.doi.org/10.1111/j.1462-5822.2009.01349.x
75. Zenobia C, Hasturk H, Nguyen D, Van Dyke TE, Kantarci A, Darveau RP. Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligaturemodel. Infect Immun 2014; 82:650-9; PMID:24478080; http://dx.doi. org/10.1128/IAI.01136-13
76. Stecher B, Maier L, Hardt WD. ’Blooming’ in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 2013; 11:277-84; PMID:23474681; http://dx.doi.org/10.1038/nrmicro2989
77. Hajishengallis G, Darveau RP, Curtis MA. The keystone- pathogen hypothesis. Nat Rev Microbiol 2012; 10:717-25; PMID:22941505; http://dx.doi.org/ 10.1038/nrmicro2873
78. Ohmori Y, Fukumoto S, Hamilton TA. Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J Immunol 1995; 155:3593-600; PMID:7561058
79. Tateno N, Matsumoto N, Motowaki T, Suzuki K, Aratani Y. Myeloperoxidase deficiency induces MIP-2 production via ERK activation in zymosan-stimulated mouse neutrophils. Free Radic Res 2013; 47:376-85; PMID:23438680; http://dx.doi.org/10.3109/ 10715762.2013.778990
80. Chandrasekar B, Smith JB, Freeman GL. Ischemiareperfusion of rat myocardium activates nuclear factor- KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001; 103:2296-302; PMID:11342480; http:// dx.doi.org/10.1161/01.CIR.103.18.2296
81. Madianos PN, Papapanou PN, Sandros J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun 1997; 65:3983-90; PMID:9316996
82. Bainbridge B, Verma RK, Eastman C, Yehia B, Rivera M, Moffatt C, Bhattacharyya I, Lamont RJ, Kesavalu L. Role of Porphyromonas gingivalis phosphoserine phosphatase enzyme SerB in inflammation, immune response, and induction of alveolar bone resorption in rats. Infect Immun 2010; 78:4560-9; PMID:20805334; http://dx.doi.org/10.1128/IAI.00703-10
83. Hajishengallis G. Aging and its impact on innate immunity and inflammation: implications for periodontitis. J Oral Biosci 2014; 56:30-7; PMID:24707191; http://dx. doi.org/10.1016/j.job.2013.09.001
84. Barnett M, Fraser A. Animal models of colitis: lessons learned, and their relevance to the clinic. In: O’Connor M, ed. Ulcerative colitis-treatments, special populations and the future. Rijeka, Croatia; Shangai, China: InTech, 2011:161-78.
85. Gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT. Mouse models of psoriasis. J Invest Dermatol 2007; 127:1292-308; PMID:17429444; http:// dx.doi.org/10.1038/sj.jid.5700807
86. t Hart BA, Gran B, Weissert R. EAE: imperfect but useful models of multiple sclerosis. Trends Mol Med 2011; 17:119-25; PMID:21251877; http://dx.doi. org/10.1016/j.molmed.2010.11.006
87. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc 2007; 2:1269-75; PMID:17546023; http://dx.doi.org/10.1038/nprot.2007.173
88. Chapple IL, Genco R, working group 2 of the joint EFPAAPw. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases. J Periodontol 2013; 84:S106-12; PMID:23631572; http://dx.doi.org/ 10.1902/jop.2013.1340011
89. Naguib G, Al-Mashat H, Desta T, Graves D. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004; 123:87-92; PMID:15191547; http://dx. doi.org/10.1111/j.0022-202X.2004.22711.x
90. Graves DT, Naguib G, Lu H, Leone C, Hsue H, Krall E. Inflammation is more persistent in Type 1 diabetic mice. J Dent Res 2005; 84:324-8; PMID:15790737; http://dx.doi.org/10.1177/154405910508400406
91. Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006; 55:487-95; PMID:16443785; http://dx.doi.org/10.2337/ diabetes.55.02.06.db05-1201
92. Liu R, Bal HS, Desta T, Behl Y, Graves DT. Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol 2006; 168:757-64; PMID:16507891; http://dx.doi.org/10.2353/ajpath.2006.050907
93. Pacios S, Kang J, Galicia J, Gluck K, Patel H, Ovaydi-Mandel A, Petrov S, Alawi F, Graves DT. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012; 26:1423-30; PMID:22179526; http://dx.doi.org/10.1096/fj.11-196279
94. Pacios S, Andriankaja O, Kang J, Alnammary M, Bae J, de Brito Bezerra B, Schreiner H, Fine DH, Graves DT. Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis. Am J Pathol 2013; 183:1928-35; PMID:24113454; http:// dx.doi.org/10.1016/j.ajpath.2013.08.017
95. Kang J, de Brito Bezerra B, Pacios S, Andriankaja O, Li Y, Tsiagbe V, Schreiner H, Fine DH, Graves DT. Aggregatibacter actinomycetemcomitans infection enhances apoptosis in vivo through a caspase-3-dependent mechanismin experimental periodontitis. Infection and immunity 2012; 80:2247-56; PMID:22451521; http://dx. doi.org/10.1128/IAI.06371-11
96. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, Kislinger T, Lu Y, Stern DM, Schmidt AM. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000; 105:1117-24; PMID:10772656; http://dx.doi.org/ 10.1172/JCI8942
97. Slocum C, Coats SR, Hua N, Kramer C, Papadopoulos G, Weinberg EO, Gudino CV, Hamilton JA, Darveau RP, Genco CA. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLOS Pathog 2014; 10:e1004215; PMID:25010102
98. Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLOS Pathog 2013; 9: e1003627; PMID:24068934
99. Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1983; 10:465-86; PMID:6579058; http://dx.doi.org/ 10.1111/j.1600-051X.1983.tb02179.x
100. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983; 18:516-26; PMID:6315909; http://dx.doi.org/ 10.1111/j.1600-0765.1983.tb00388.x
101. Caton J, Ryan ME. Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacol Res 2011; 63:114-20; PMID:21182947; http://dx.doi.org/ 10.1016/j.phrs.2010.12.003
102. Iyer RP, Patterson NL, Fields GB, Lindsey ML. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 2012; 303:H919-30; PMID:22904159; http://dx.doi.org/10.1152/ajpheart.00577.2012